In the latest trading session, 41.74 million 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) shares changed hands as the company’s beta touched 2.19. With the company’s most recent per share price at $3.61 changing hands around $1.81 or 100.73% at last look, the market valuation stands at $5.32M. SXTP’s current price is a discount, trading about -896.95% off its 52-week high of $35.99. The share price had its 52-week low at $1.41, which suggests the last value was 60.94% up since then. When we look at 60 Degrees Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 23180.0 shares, with the 3-month average coming to 460.24K.
Analysts gave the 60 Degrees Pharmaceuticals Inc (SXTP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SXTP as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. 60 Degrees Pharmaceuticals Inc’s EPS for the current quarter is expected to be -1.32.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Instantly SXTP is in green as seen in intraday trades today. With action 91.01%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -44.03%, with the 5-day performance at 91.01% in the green. However, in the 30-day time frame, 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) is 147.26% up. Looking at the short shares, we see there were 51389.0 shares sold at short interest cover period of 0.66 days.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
Year-over-year growth is forecast to reach 165.24% up from the last financial year.
Consensus estimates given by 2 financial analysts project the company’s revenue in the current quarter to hit an average of 301k. 2 analysts are of the opinion that 60 Degrees Pharmaceuticals Inc’s revenue for the current quarter will be 376.5k. The company’s revenue for the corresponding quarters a year ago was 116.46k and 124.97k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 158.46%. The estimates for the next quarter sales put growth at 201.27%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.29%. The 2025 estimates are for 60 Degrees Pharmaceuticals Inc earnings to increase by 81.77%, but the outlook for the next 5-year period is at 71.59% per year.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.33% of 60 Degrees Pharmaceuticals Inc shares while 2.09% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.18%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund. With 775.0 shares estimated at $3092.0 under it, the former controlled 0.05% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.03% of the shares, roughly 427.0 shares worth around $1703.0.
